Live Latest news on the coronavirus
Immunization Messenger RNA vaccines: a new type of immunization that will not modify your DNA
In a multi-hospital analysis of people who had experienced an allergic reaction to their first dose of the covid-19 vaccine based on messenger RNA (mRNA) technology,
all those who received a second dose tolerated it without complications
. The research, led by allergists at Massachusetts General Hospital (MGH) and just published in
JAMA Internal Medicine
, indicates that a first-dose reaction to the covid-19 vaccine should not prevent people from receiving a second dose.
The
allergic reactions
after administration of a vaccine with a mRNA product against covid-19 are estimated at
2% of vaccinees
, and
anaphylaxis
, up to
2.5 in 10,000 people
.
To
examine whether it is safe to give a second dose
of this type of vaccine
after a reaction to the first
dose, a team of researchers from MGH, Vanderbilt University Medical Center, University of Texas Southwestern Medical Center and Yale School of Medicine combined
data from patients who sought care from an allergist
at their hospitals for a reaction to a first dose.
"These reactions included symptoms such as
itching
,
hives
or
redness
. All included patients were counseled by allergy specialists after their reaction to the first dose," explains co-lead author
Matthew S. Krantz
of Vanderbilt University Medical Center.
Among
189 vaccinees
studied, 32 (
17%
) experienced
anaphylaxis
after their first dose of vaccine.
A total of 159 patients (84%) received the second dose.
All 159 patients, including 19 individuals who had experienced anaphylaxis with the first, tolerated the second dose well
.
Thirty-two patients (
20%
) reported
immediate and allergic symptoms
associated with the second dose, although these were mild and self-limited, or resolved with antihistamines.
Reactions
"An important aspect of this study is that these reactions to the immediate-onset mRNA vaccine may not be mechanically caused by the classic allergy, called
immediate
hypersensitivity or IgE-mediated hypersensitivity
. For classic allergy, re-exposure to the allergen causes the same or even worse symptoms, "says co-lead author
Kimberly G. Blumenthal
, co-director of the Clinical Epidemiology Program within MGH's Division of Rheumatology, Allergy and Immunology.
The study findings suggest that it
is safe for most people to receive a second dose of the mRNA vaccine
, says another study co-lead author,
Aleena Banerji
, who is clinical director of MGH's Allergy and Clinical Immunology Unit.
"After reactions to the first dose, allergy specialists can be helpful in helping guide benefit / risk assessments and safely complete a vaccination."
According to the criteria of The Trust Project
Know more
Science and Health
Coronavirus
Covid 19
Infectious diseases
Respiratory diseases
Vaccines
Pfizer vaccine
Health Why does the Covid vaccine hurt?
Health The 4 vaccines approved in the EU provide high protection against circulating strains
Coronavirus: The Differences Between Pfizer, Moderna, AstraZeneca and Janssen Vaccines
See links of interest
Last News
Gay from Liebana
Work calendar
Home THE WORLD TODAY
Master Investigation Journalism
Tokyo 2020
Basketball: Japan - Spain
Sara Sorribes - Anastasia Pavlyuchenkova, live
Alison Van Uytvanck - Garbiñe Muguruza, live
Paula Badosa - Nadia Podoroska, live
France-Spain, live